A perspective review on factors that influence mutagenicity in medicinal plants and their health implications
Toxicological Sciences · 2025
DOI: 10.1093/toxsci/kfaf004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Toxicological Sciences, 2025. Verfasst von Victoria Fasiku und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of the Free State, Bloemfontein 9300, South Africa. Hauptthemen laut MEDLINE: Plants, Medicinal, Mutagens, Mutagenesis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Medicinal plants are products from natural sources that have found relevance in medicine for several decades. They are rich in bioactive compounds; thus, they are widely used to treat different ailments globally. Medicinal plants have provided hope for the healthcare industry as most are used to synthesize modern medicines currently used in the treatment of various diseases. However, there are still concerns with respect to the mutagenic properties of medicinal plants. Over the years, researchers have embarked on various studies aimed at investigating the mutagenicity of several medicinal plants found in different regions of the world. In this review, we discussed factors that may influence plant mutagenicity and the findings of in vitro and in vivo mutagenicity studies of several medicinal plants from across the globe. In addition, this review considers the potential health implications of mutagenic medicinal plants and safety measures that can be used to mitigate mutagenesis in medicinal plants. To achieve this, we searched for articles reporting on medicinal plants and mutagenesis on the PubMed, Scopus, and Web of Science databases. Several journal articles reported on the mutagenicity of some medicinal plants; however, it was observed that the majority of the articles reported the nonmutagenicity of medicinal plants. The findings from these studies imply that medicinal plants have good prospects in treating diseases and that they are clinically relevant. However, these reports will require further validation to determine their safety for human use as limited in vivo studies were conducted and there are no clinical safety reports for any of the plants discussed in this review.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of the Free State, Bloemfontein 9300, South Africa.
- Cancer Research and Molecular Biology Laboratories, Department of Biochemistry, College of Medicine, University of Ibadan, Ibadan 200005, Nigeria.
- Laser Research Center, Faculty of Health Sciences, University of Johannesburg, Doornfontein 2028, South Africa.
Zitieren
APA
Fasiku, V., Kyagaba, D., Hlalele, A., Adegoke, A., Erukainure, O. L., & Sekhoacha, M. (2025). A perspective review on factors that influence mutagenicity in medicinal plants and their health implications. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfaf004
Vancouver
Fasiku V, Kyagaba D, Hlalele A, Adegoke A, Erukainure OL, Sekhoacha M. A perspective review on factors that influence mutagenicity in medicinal plants and their health implications. Toxicological Sciences. 2025. doi:10.1093/toxsci/kfaf004
BibTeX
@article{Fasiku2025,
author = {Fasiku, Victoria and Kyagaba, Doreen and Hlalele, Atlehang and Adegoke, Ayodeji and Erukainure, Ochuko L and Sekhoacha, Mamello},
title = {A perspective review on factors that influence mutagenicity in medicinal plants and their health implications},
journal = {Toxicological Sciences},
year = {2025},
doi = {10.1093/toxsci/kfaf004}
}
EUVIMED